Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Maryland
Biotech
Sirnaomics nabs a rare series E worth $105M
It’s a case of déjà vu (and no IPO) for the U.S.-China RNAi biotech Sirnaomics as it grabs a second $105 million funding round.
Ben Adams
Jul 2, 2021 10:56am
OncoImmune nabs $56M round for late-stage COVID tests, leukemia
Sep 9, 2020 9:05am
AstraZeneca spinout bags $250M series A
Feb 28, 2018 8:51am
CDMO Pharmaceutics International gains $93M investment, new president
Sep 7, 2016 10:52am
